Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-11-047352
Filing Date
2011-08-15
Accepted
2011-08-15 16:52:27
Documents
11
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 v231017_10q.htm 10-Q 542838
2 v231017_ex31-1.htm EX-31.1 16367
3 v231017_ex31-2.htm EX-31.2 16037
4 v231017_ex32-1.htm EX-32.1 6383
5 v231017_ex32-2.htm EX-32.2 6269
  Complete submission text file 0001144204-11-047352.txt   1804034

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT vtus-20110630.xml EX-101.INS 146503
7 XBRL TAXONOMY EXTENSION SCHEMA vtus-20110630.xsd EX-101.SCH 13803
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vtus-20110630_cal.xml EX-101.CAL 29943
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vtus-20110630_def.xml EX-101.DEF 84201
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtus-20110630_lab.xml EX-101.LAB 93046
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtus-20110630_pre.xml EX-101.PRE 89330
Mailing Address 787 7TH AVENUE 48TH FLOOR NEW YORK NY 10019
Business Address 787 7TH AVENUE 48TH FLOOR NEW YORK NY 10019 (212) 554-4388
VENTRUS BIOSCIENCES INC (Filer) CIK: 0001426800 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-35005 | Film No.: 111037337
SIC: 2834 Pharmaceutical Preparations